business
US 100% Tariff on Generic Drugs Threatens Indian Pharma’s Largest Export Market
Washington’s planned tariff could disrupt India’s pharmaceutical exports to the US, which accounted for 37% of its $26 billion pharma exports in 2025, while pushing Indian firms toward higher-value medicines.
